Baidu
map

卢洪洲教授艾滋病研究课题获上海医学科技奖一等奖

2017-04-28 MedSci MedSci原创

2017年4月25日,第十五届上海医学科技奖颁奖大会在沪举行,复旦大学附属上海市公共卫生临床中心卢洪洲教授教授领衔的科研项目《艾滋病及其相关疾病临床路径的建立与推广应用》,荣获上海市医学科技奖一等奖。全球累计有6500万例人感染HIV,累计死亡2500多万例,目前,存活的HIV感染者约3690万例。但令人不安的是,当前仍有1710万例并不知道自己已经感染了艾滋病毒,2200万例感染者还无法得到规范



2017年4月25日,第十五届上海医学科技奖颁奖大会在沪举行,复旦大学附属上海市公共卫生临床中心卢洪洲教授教授领衔的科研项目《艾滋病及其相关疾病临床路径的建立与推广应用》,荣获上海市医学科技奖一等奖。

全球累计有6500万例人感染HIV,累计死亡2500多万例,目前,存活的HIV感染者约3690万例。但令人不安的是,当前仍有1710万例并不知道自己已经感染了艾滋病毒,2200万例感染者还无法得到规范的抗病毒治疗(主要分布在非洲等社会动荡或是经济欠发达地区),这不仅会导致感染者本人错过最佳治疗时机,同时,对亲人和朋友也是一种潜在的感染威胁。

截至2015年底,中国发现现存活的艾滋病病毒感染者共计57.7万例,新增感染9.7万例,累计死亡17.7万人。测算估计,全国人群HIV总感染率0.06%,即每1万人中有6人“染艾”,仍有32.1%感染者未被发现。



卢洪洲教授团队根据循证医学证据和我国艾滋病诊疗常规为指导,结合团队多年来积累的临床经验,形成了一个种既能贯彻医院质量管理标准,又能节约资源的医疗标准和模式——临床路径。本项目是国内首个在艾滋病领域中设立并在全国推广应用的临床路径。内容涵盖艾滋病抗病毒治疗、机会性感染、HIV相关肿瘤、合并其他疾病、免疫重建炎性反应综合征、药物相关不良反应、职业暴露、艾滋病恐惧症等多种艾滋病及其相关疾病的临床路径。

上海医学科技奖由上海医学会设立,旨在表彰奖励在医学领域科技进步中作出贡献的优秀个人和集体,促进上海医学科技事业的发展。

相关介绍

卢洪洲(1966--),主任医师、教授、内科学博士、留美博士后、内科学博士生导师、护理学博士生导师。享受国务院特殊津贴、入选国家百千万人才工程、“有突出贡献中青年专家”。现任上海市(复旦大学附属)公共卫生临床中心党委书记、复旦大学附属华山医院院长助理。

以第一作者或通讯作者在国内外发表各类论文380余篇,其中在SCI引用杂志包括《NewEnglandJournalofMedicine》、《EmergingInfectiousDiseases》、《AIDS》、《Plosone》、《JournalofClinicalMicrobiology》发表论着100余篇;主编专业参考书11部。已获8项省部级科技成果奖、获专利4项。先后入选:国家百千万人才工程、“有突出贡献中青年专家”、2015年 “最美援外医生”、 2014年度“影响中国”科技人物; “上海领军人才”、“上海市优秀学科带头人”、“上海市医学领军人才”;先后荣获全国医药卫生系统先进个人、全国抗击“非典”先进个人、中国医药科技创新人物、团中央与全国学联“中国大学生跨世纪发展奖励基金”;上海市五一劳动奖章获得者、上海市卫生系统 “银蛇奖”、文明职工、“创新之星”;上海市卫生局先进工作者并行政记大功一次、上海市科委“明治乳业科学奖”、上海市科普创新贡献奖;第二届“上海市人道博爱奖”。美国肝病学会-亚太肝病学会奖、艾滋病国际倡导联盟“精忠奖”。先后承担:国家“十一五”、“十二五” 、“十三五”传染病重大专项、 “十二五”新药创制平台、“863”、“973”(子课题)、国家自然科学基金(五项);美国盖茨基金、美国NIH项目(二项);国家临床重点专科、国家卫计委、上海市科委基金、上海市卫计委“公共卫生三年行动计划”(二项)、上海申康医院发展中心等30余项科研课题;负责中国药物临床试验机构(艾滋病专业组与I期)的研究项目。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1811135, encodeId=6524181113573, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 28 23:00:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771242, encodeId=f21a1e7124299, content=<a href='/topic/show?id=96483655e04' target=_blank style='color:#2F92EE;'>#卢洪洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36557, encryptionId=96483655e04, topicName=卢洪洲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39fc38222316, createdName=lvygwyt2794, createdTime=Wed Mar 14 21:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721453, encodeId=44f71e214532c, content=<a href='/topic/show?id=c7c5e4947cb' target=_blank style='color:#2F92EE;'>#科技奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74947, encryptionId=c7c5e4947cb, topicName=科技奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=423733003907, createdName=w363522460, createdTime=Mon Apr 02 14:00:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192101, encodeId=122c192101b2, content=祝贺卢教授及其团队, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a571628825, createdName=2863454482, createdTime=Sun Apr 30 09:27:59 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191578, encodeId=62a31915e8f5, content=复旦大学附属上海市公共卫生临床中心卢洪洲教授教授领衔的科研项目《艾滋病及其相关疾病临床路径的建立与推广应用》, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Fri Apr 28 22:21:25 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191549, encodeId=15ac1915493e, content=祝贺卢教授, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 18:25:56 CST 2017, time=2017-04-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1811135, encodeId=6524181113573, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 28 23:00:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771242, encodeId=f21a1e7124299, content=<a href='/topic/show?id=96483655e04' target=_blank style='color:#2F92EE;'>#卢洪洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36557, encryptionId=96483655e04, topicName=卢洪洲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39fc38222316, createdName=lvygwyt2794, createdTime=Wed Mar 14 21:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721453, encodeId=44f71e214532c, content=<a href='/topic/show?id=c7c5e4947cb' target=_blank style='color:#2F92EE;'>#科技奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74947, encryptionId=c7c5e4947cb, topicName=科技奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=423733003907, createdName=w363522460, createdTime=Mon Apr 02 14:00:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192101, encodeId=122c192101b2, content=祝贺卢教授及其团队, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a571628825, createdName=2863454482, createdTime=Sun Apr 30 09:27:59 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191578, encodeId=62a31915e8f5, content=复旦大学附属上海市公共卫生临床中心卢洪洲教授教授领衔的科研项目《艾滋病及其相关疾病临床路径的建立与推广应用》, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Fri Apr 28 22:21:25 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191549, encodeId=15ac1915493e, content=祝贺卢教授, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 18:25:56 CST 2017, time=2017-04-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1811135, encodeId=6524181113573, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 28 23:00:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771242, encodeId=f21a1e7124299, content=<a href='/topic/show?id=96483655e04' target=_blank style='color:#2F92EE;'>#卢洪洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36557, encryptionId=96483655e04, topicName=卢洪洲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39fc38222316, createdName=lvygwyt2794, createdTime=Wed Mar 14 21:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721453, encodeId=44f71e214532c, content=<a href='/topic/show?id=c7c5e4947cb' target=_blank style='color:#2F92EE;'>#科技奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74947, encryptionId=c7c5e4947cb, topicName=科技奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=423733003907, createdName=w363522460, createdTime=Mon Apr 02 14:00:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192101, encodeId=122c192101b2, content=祝贺卢教授及其团队, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a571628825, createdName=2863454482, createdTime=Sun Apr 30 09:27:59 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191578, encodeId=62a31915e8f5, content=复旦大学附属上海市公共卫生临床中心卢洪洲教授教授领衔的科研项目《艾滋病及其相关疾病临床路径的建立与推广应用》, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Fri Apr 28 22:21:25 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191549, encodeId=15ac1915493e, content=祝贺卢教授, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 18:25:56 CST 2017, time=2017-04-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1811135, encodeId=6524181113573, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 28 23:00:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771242, encodeId=f21a1e7124299, content=<a href='/topic/show?id=96483655e04' target=_blank style='color:#2F92EE;'>#卢洪洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36557, encryptionId=96483655e04, topicName=卢洪洲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39fc38222316, createdName=lvygwyt2794, createdTime=Wed Mar 14 21:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721453, encodeId=44f71e214532c, content=<a href='/topic/show?id=c7c5e4947cb' target=_blank style='color:#2F92EE;'>#科技奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74947, encryptionId=c7c5e4947cb, topicName=科技奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=423733003907, createdName=w363522460, createdTime=Mon Apr 02 14:00:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192101, encodeId=122c192101b2, content=祝贺卢教授及其团队, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a571628825, createdName=2863454482, createdTime=Sun Apr 30 09:27:59 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191578, encodeId=62a31915e8f5, content=复旦大学附属上海市公共卫生临床中心卢洪洲教授教授领衔的科研项目《艾滋病及其相关疾病临床路径的建立与推广应用》, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Fri Apr 28 22:21:25 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191549, encodeId=15ac1915493e, content=祝贺卢教授, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 18:25:56 CST 2017, time=2017-04-28, status=1, ipAttribution=)]
    2017-04-30 2863454482

    祝贺卢教授及其团队

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1811135, encodeId=6524181113573, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 28 23:00:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771242, encodeId=f21a1e7124299, content=<a href='/topic/show?id=96483655e04' target=_blank style='color:#2F92EE;'>#卢洪洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36557, encryptionId=96483655e04, topicName=卢洪洲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39fc38222316, createdName=lvygwyt2794, createdTime=Wed Mar 14 21:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721453, encodeId=44f71e214532c, content=<a href='/topic/show?id=c7c5e4947cb' target=_blank style='color:#2F92EE;'>#科技奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74947, encryptionId=c7c5e4947cb, topicName=科技奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=423733003907, createdName=w363522460, createdTime=Mon Apr 02 14:00:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192101, encodeId=122c192101b2, content=祝贺卢教授及其团队, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a571628825, createdName=2863454482, createdTime=Sun Apr 30 09:27:59 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191578, encodeId=62a31915e8f5, content=复旦大学附属上海市公共卫生临床中心卢洪洲教授教授领衔的科研项目《艾滋病及其相关疾病临床路径的建立与推广应用》, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Fri Apr 28 22:21:25 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191549, encodeId=15ac1915493e, content=祝贺卢教授, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 18:25:56 CST 2017, time=2017-04-28, status=1, ipAttribution=)]
    2017-04-28 inter158

    复旦大学附属上海市公共卫生临床中心卢洪洲教授教授领衔的科研项目《艾滋病及其相关疾病临床路径的建立与推广应用》

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1811135, encodeId=6524181113573, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 28 23:00:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771242, encodeId=f21a1e7124299, content=<a href='/topic/show?id=96483655e04' target=_blank style='color:#2F92EE;'>#卢洪洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36557, encryptionId=96483655e04, topicName=卢洪洲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39fc38222316, createdName=lvygwyt2794, createdTime=Wed Mar 14 21:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721453, encodeId=44f71e214532c, content=<a href='/topic/show?id=c7c5e4947cb' target=_blank style='color:#2F92EE;'>#科技奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74947, encryptionId=c7c5e4947cb, topicName=科技奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=423733003907, createdName=w363522460, createdTime=Mon Apr 02 14:00:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192101, encodeId=122c192101b2, content=祝贺卢教授及其团队, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a571628825, createdName=2863454482, createdTime=Sun Apr 30 09:27:59 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191578, encodeId=62a31915e8f5, content=复旦大学附属上海市公共卫生临床中心卢洪洲教授教授领衔的科研项目《艾滋病及其相关疾病临床路径的建立与推广应用》, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Fri Apr 28 22:21:25 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191549, encodeId=15ac1915493e, content=祝贺卢教授, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 18:25:56 CST 2017, time=2017-04-28, status=1, ipAttribution=)]
    2017-04-28 lovetcm

    祝贺卢教授

    0

相关资讯

Mol Ther:基因编辑技术剔除小鼠艾滋病病毒:只杀病毒不伤细胞

美国天普大学华人科学家胡文辉等人近日报告说,他们利用基因编辑技术,有效剔除了一种人源化小鼠多个器官组织中的人类艾滋病病毒,朝着开展人类临床试验的方向迈出一大步。 此前,胡文辉等人已成功利用基因编辑技术,有效清除了体外培养的人类细胞系、艾滋病患者体内取出的T免疫细胞以及转基因小鼠体内的艾滋病病毒。 人源化BLT小鼠是指移植了人的骨髓、肝和胸腺组织或细胞的免疫缺陷小鼠。这种小鼠具有人类功能

HIV免疫疗法获重大突破,一览研究进展

近日,关于HIV免疫疗法迎来了两项新突破。来自美国TSRI和中国上海科技大学的研究人员成功构建出抵抗HIV的免疫细胞,有望治愈HIV感染;美国天普大学华人科学家胡文辉等人利用基因编辑技术,从多靶点高效剔除了一种人源化小鼠多个器官组织中的人类HIV病毒。近日,关于HIV免疫疗法迎来了两项新突破:来自美国TSRI和中国上海科技大学的研究人员成功构建出抵抗HIV的免疫细胞,有望治愈HIV感染;美国天

如何利用多种抗体疗法来攻克癌症及艾滋病?

如今,癌症和艾滋病可谓是人们所面对的两大棘手的疾病难题,当然为了攻克这两种疾病,科学家们也在不断探索,不断开发新型疗法来治疗这些疾病;近些年来,随着科学家们研究的深入,他们开发出了特殊的抗体疗法来治疗癌症和艾滋病;近日,斯克里普斯研究所就开发出了新型的抗体药物偶联药物来治疗癌症,研究者发现,他们所开发的这种抗体-药物键合物(ADCs)药物有望治疗一些实体瘤和血液癌症。 此外,发表在S

PLOS PATHOG:找到HIV“顽固存在”的根源,或能将其斩草除根

在HIV的治疗领域,长久以来一直有着引起医学界争论的问题,究竟是长期接受抗逆转录病毒(ART)治疗患者体内的微量HIV引起了炎症并激活了免疫系统,还是炎症和激活的免疫系统导致了ART治疗期间患者体内依然存在微量HIV病毒?

PNAS:新型抗HIV免疫细胞正式进入美国临床试验

Scripps研究所(TSRI)的科学家们制造出一种能对抗艾滋病病毒的免疫细胞。在实验室条件下测试结果显示,这些抗病毒细胞能迅速取代患病的免疫细胞。具有极高的临床价值,有望治愈HIV疾病。Scripps研究所(TSRI)的科学家们制造出一种能对抗艾滋病病毒的免疫细胞。在实验室条件下测试结果显示,这些抗病毒细胞能迅速取代患病的免疫细胞。具有极高的临床价值,有望治愈HIV疾病。“这是一种长效保护,”T

俄罗斯科学家尝试从基因层面攻克艾滋病

俄罗斯圣彼得堡大学基因组生物信息中心的科学家正致力于对基因抗性的研究,拟通过研究部分欧洲人种对艾滋病毒具有先天免疫性的现象,找到治疗艾滋病的有效途径。感染人体的艾滋病病毒,其体积仅有红血细胞的 1 /60 大小,感染人体后可迅速繁殖至 100 亿且每千万复制体出现突变,艾滋病毒的易变异性及其能附着至人体 DNA 结构的特性,使得寻找有效的药物变得异常困难。

Baidu
map
Baidu
map
Baidu
map